
Referral‑fee transparency and potential estate‑agent regulation could reshape the UK conveyancing market, protecting consumers and ensuring firms remain financially viable.
The Council for Licensed Conveyancers (CLC) has moved from a promise made in July to an active data‑driven review of referral fees in the conveyancing sector. Triggered by a BBC Panorama investigation into "conditional selling"—where estate agents steer buyers toward in‑house legal services—the regulator now scrutinises the fee disclosures firms submit in their annual returns. While firms already report these payments, the CLC argues that the information surfaces too late, and that the agents receiving the fees should be the ones informing clients. This shift underscores a broader push for greater market transparency.
Parallel to the CLC’s initiative, the Chartered Institute of Legal Executives (CILEX) has pressed for regulatory action against high‑volume, low‑fee conveyancing practices that may compromise service quality and consumer protection. The CLC, however, cautions against a blanket approach, noting that larger firms often possess robust systems and lower risk profiles. Instead, the regulator emphasizes a nuanced, risk‑based framework that targets specific vulnerabilities rather than firm size alone. This dialogue reflects an industry grappling with balancing efficiency, cost pressures, and the need for sustainable business models.
Looking ahead, the review’s findings could intersect with the government’s proposed Interest on Lawyers’ Client Accounts (IOLTA) scheme. As conveyancers hold substantial client funds, any reliance on interest income could affect financial stability, especially for smaller practices. The CLC has already flagged concerns about firms becoming overly dependent on such revenue streams. By addressing referral fee structures and potential IOLTA implications, the regulator aims to safeguard consumer interests while ensuring the conveyancing market remains resilient and competitive in a post‑Panorama landscape.
Comments
Want to join the conversation?
Loading comments...